Clinical Trial Update: Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating guselkumab in adults with Pyoderma gangrenosum and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyoderma Gangrenosum

Drugs mentioned

• TREMFYA (guselkumab)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Pyoderma Gangrenosum, Skin Diseases | Phase 2 | Status: RECRUITING